IL105822A - Pharmaceutical products useful for treatment of tropical spastic paresis - Google Patents

Pharmaceutical products useful for treatment of tropical spastic paresis

Info

Publication number
IL105822A
IL105822A IL10582293A IL10582293A IL105822A IL 105822 A IL105822 A IL 105822A IL 10582293 A IL10582293 A IL 10582293A IL 10582293 A IL10582293 A IL 10582293A IL 105822 A IL105822 A IL 105822A
Authority
IL
Israel
Prior art keywords
thr
peptide
cys
ser
amide
Prior art date
Application number
IL10582293A
Other languages
English (en)
Other versions
IL105822A0 (en
Original Assignee
Advanced Peptides & Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Peptides & Biotech filed Critical Advanced Peptides & Biotech
Publication of IL105822A0 publication Critical patent/IL105822A0/xx
Publication of IL105822A publication Critical patent/IL105822A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL10582293A 1992-06-15 1993-05-28 Pharmaceutical products useful for treatment of tropical spastic paresis IL105822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/898,691 US6242564B1 (en) 1986-06-03 1992-06-15 Treatment of tropical spastic paresis with peptide T

Publications (2)

Publication Number Publication Date
IL105822A0 IL105822A0 (en) 1993-09-22
IL105822A true IL105822A (en) 1999-11-30

Family

ID=25409893

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10582293A IL105822A (en) 1992-06-15 1993-05-28 Pharmaceutical products useful for treatment of tropical spastic paresis

Country Status (8)

Country Link
US (1) US6242564B1 (de)
EP (1) EP0579363B1 (de)
JP (1) JPH06247874A (de)
AT (1) ATE198987T1 (de)
AU (1) AU671989B2 (de)
DE (1) DE69329899T2 (de)
DK (1) DK0579363T3 (de)
IL (1) IL105822A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
US5567682A (en) * 1988-12-16 1996-10-22 Advanced Peptides And Biotechnology Sciences Method of treating Alzheimer's disease
ES2220915T3 (es) * 1993-09-24 2004-12-16 Advanced Immuni T, Inc. Peptidos lineales y ciclicos para el tratamiento o prevencion de la enfermedad de crohn y/o colitis ulcerosa.
DE69433763T2 (de) * 1993-09-24 2005-04-14 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis
AUPM365794A0 (en) * 1994-02-02 1994-02-24 Minister for Agriculture & Rural Affairs for the State of NSW, The Biocontrol of take-all using phialophora sp. (lobed hyphopodia)
WO1997031628A1 (en) * 1996-02-28 1997-09-04 Innapharma, Inc. Peptidomimetics for the treatment of hiv infection
MXPA02004619A (es) * 1999-11-09 2004-09-10 Advanced Immuni T Inc Metodo para tratar enfermedades virales y otros trastornos, alterando la expresion del gen inmediato mediante la administracion del peptido t.
US7700115B2 (en) 2005-06-23 2010-04-20 Rapid Pharmaceuticals Ag Therapeutic peptides and vaccines
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
US10501494B2 (en) 2013-04-26 2019-12-10 Creative Bio-Peptides Uses of peptides to treat brain injury and disease
US10624944B2 (en) * 2017-06-19 2020-04-21 Creative Bio-Peptides Inc. Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)
USRE50630E1 (en) 2017-10-31 2025-10-14 Creative BioPeptides, Inc. Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
AU7544987A (en) * 1986-06-03 1988-01-11 Pert, C.B. Small peptides which inhibit binding to t-4 receptors
ATE96450T1 (de) * 1986-06-03 1993-11-15 Us Commerce Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
WO1989012067A1 (en) * 1988-05-27 1989-12-14 The United States Of America, As Represented By Th Compositions having use as treatment of psoriasis and neuropsychiatric deficits
US5689398A (en) * 1996-01-03 1997-11-18 Allen-Bradley Company, Inc. Redundant control relay circuits

Also Published As

Publication number Publication date
IL105822A0 (en) 1993-09-22
DE69329899T2 (de) 2001-05-23
EP0579363A1 (de) 1994-01-19
DE69329899D1 (de) 2001-03-08
DK0579363T3 (da) 2001-02-19
US6242564B1 (en) 2001-06-05
AU671989B2 (en) 1996-09-19
JPH06247874A (ja) 1994-09-06
EP0579363B1 (de) 2001-01-31
AU3871993A (en) 1993-12-16
ATE198987T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
US5834429A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
US6242564B1 (en) Treatment of tropical spastic paresis with peptide T
WO1991013088A1 (en) Terminally blocked antiviral peptides
Brahn et al. Total lymphoid irradiation therapy in refractory rheumatoid arthritis
EP0249390A2 (de) Synthetische Peptide, die vom HIV-Glycoprotein gp 120 abgeleitet sind
US5063206A (en) Compositions having use as treatment of neuropsychiatric deficits
CA2187336A1 (en) Pharmaceutical formulations for treating japanese cedar pollen allergy
Lau et al. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.
AU663875B2 (en) Compositons for the treatment of chronic fatigue syndrome
EP0415999B1 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
EP0249394B1 (de) Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken
Al-Nakib et al. Prevention and treatment of experimental influenza A virus infection in volunteers with a new antiviral ICI 130,685
JP3520084B2 (ja) 多発性硬化症を含めた炎症の治療におけるペプチドｔ及びその関連ペプチド類
US5248667A (en) Method of treating psoriasis using synthetic peptide compositions
EP0335726A2 (de) Verwendung von Thymopentin und Derivaten bei der Behandlung von HIV-Patienten
JP2680011B2 (ja) Ｔ−４レセプターへの結合を阻害し免疫原として作用する小ペプチド類
DE69130571T2 (de) Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen
Barcellini et al. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy
AP96A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens.
US6593455B2 (en) Tripeptide amides that block viral infectivity and methods of use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees